Background. Mycoplasma pneumoniae is one of the most common pathogens that causes community-acquired respiratory tract infection. Outbreaks are well known, and all age groups are susceptible. An outbreak in an army training unit afforded an opportunity to identify possible risk factors for morbidity.
Mycoplasma pneumoniae is a common respiratory pathogen that affects both the upper and lower respiratory tracts in all age groups [1] [2] [3] . This agent is estimated to be responsible for ∼15%-20% of all cases of community-acquired pneumonia (CAP) and for up to 40% of cases of CAP among children [3] [4] [5] . Thus, it is 1 of M. pneumoniae infection can be found worldwide, with peaks occurring every 3-5 years [4, 7] . Outbreaks have been described in closed-community settings [8] [9] [10] [11] . Most outbreaks evolve gradually [12] ; however, point source acute outbreaks in which many people are infected simultaneously occur in closed or semiclosed settings. In this study, we describe an acute M. pneumoniae outbreak that occurred in an army unit of basic trainees.
Comparison of healthy individuals with patients who have respiratory illness enabled us to identify risk factors for acquiring infection.
METHODS

Outbreak Description
On 19 September 2004, a report of an unusual cluster of respiratory tract illness in 11 soldiers was received at the Army Health Branch of the Israeli Defense Force Medical Corps (Ramat-Gan, Israel). An epidemiologic investigation, started the following day, revealed that morbidity was confined to a single unit in a training camp. This unit numbered 91 male soldiers aged 18-21 years (75 of whom were 18-19-year-old recruits and 16 of whom were command staff). All were otherwise healthy. The trainees lived in confined quarters and slept in close proximity to each other. Acute urine and serum samples were obtained from 72 soldiers. Throat and nasopharyngeal specimens were obtained from soldiers who complained of any signs of respiratory illness and who had an oral temperature of at least 37.0ЊC in the preceding 48 h ( ). All sympn p 38 tomatic soldiers were treated with azithromycin (500 mg/day for 7 days) within 1 week after the first visit by the investigative team. At the second visit 2 weeks later, convalescent-phase serum samples were obtained from 42 of the original 72 soldiers and from an additional 6 soldiers. The distribution of samples by clinical definition is given in table 1. On both visits, soldiers completed questionnaires regarding current morbidity, time of disease onset, and risk factors such as number and age of siblings, military function (i.e., command staff or trainee), and smoking habits. Soldiers who reported smoking at least 1 cigarette a day at the time of the outbreak were defined as smokers.
The number of cigarettes per day per smoker ranged from 1 to 15 ( , ) . Soldiers were asked to subjecmean ‫ע‬ SD 6.7 ‫ע‬ 4.2 tively grade their various clinical signs (except sputum production and rhinorrhea) as "mild" or "moderate."
Case definition. Symptomatic soldiers were categorized as follows: (1) respiratory tract infection (RTI), defined as an oral temperature of at least 37.3ЊC accompanied by у1 of the following symptoms: sore throat, cough, rhinorrhea, or headache (41 patients); (2) febrile RTI, defined as an infection with the same symptoms as RTI, but with an oral temperature of at least 37.8ЊC (29 patients from within the RTI category); and (3) pneumonia, determined by a diagnosis of pneumonia by chest radiography (10 patients from within the RTI category). These soldiers were compared with a control group of 50 soldiers from the same unit who were present at the time of the outbreak but who did not have respiratory symptoms or who had an oral temperature !37.3ЊC.
Serologic controls. A collection of 40 paired serum samples obtained 1-3 months apart from soldiers not related to the outbreak [13] was used to determine cutoffs for seroconversion (see the section Serologic Testing below). Twenty of these samples were collected from soldiers who had performed their basic training in the same camp 2 years previously, and the other 20 samples were obtained from recruits at another basic training camp approximately during the time of the outbreak.
Laboratory Methods
Duplicate throat samples were obtained from 38 available patients, of whom 25 had an oral temperature of at least 37.3ЊC. One sample from each subject was inoculated on blood agar for detection of Streptococcus pyogenes. The other was transferred to 4 mL of SP4 medium and used for M. pneumoniae culture and molecular detection [14] . Molecular detection was performed by an in-house specific nested PCR (PCR1), as previously described [15, 16] . This test was shown in our laboratory to have a detection limit of ∼20 CFU/mL when using the type strain M129 (ATCC 29342) and a clinical isolate dating from before this outbreak. A real-time PCR assay specific for M. pneumoniae was performed at the Centers for Disease Control and Prevention (Atlanta, GA) to confirm the PCR1 results. The real-time PCR assay can detect !5 genome copies of the M. pneumoniae ATPase gene [17] -thus, the real-time PCR assay was, at a minimum, 4 times more sensitive than PCR1. Molecular subtyping of the epidemic strain was performed as recently described [18] .
Detection of Legionella and Chlamydophila species. Nine urine samples were tested for the presence of Legionella pneumophila serogroup 1 antigen (NOW Legionella Urinary Immunochromatographic Antigen Test; Binax). All swabs were tested for Chlamydophila pneumoniae DNA as described by Black et al. [19] .
Virus detection. Nasopharyngeal swabs (Virocult; MW&E) were examined for the presence of respiratory syncytial virus, influenza A and B viruses, parainfluenza viruses, and adenovirus by direct immunofluorescence assay using commercial monoclonal antibodies (Chemicon International) and by tissue culture. PCR and RT-PCR were used as previously described [20] [21] [22] to test for the presence of adenovirus, influenza viruses, and human metapneumovirus by real-time PCR.
Serologic Testing
Acute-phase serum samples (defined as having been obtained at the first visit) and convalescent-phase serum samples (defined as having been obtained at the second visit 2 weeks later) were tested for specific anti-M. pneumoniae IgA, IgG, and IgM antibodies using SeroMP ELISA kits (IgG, IgM, and IgA; Savyon Diagnostics). Results were then calculated for each serum sample as arbitrary binding units (BU) per mL, according to a calibration curve. Seroconversion was determined if the increase in IgA, IgM, or IgG levels between the convalescent-and acute-phase serum samples was higher than the mean increase plus 2 SDs of the serologic control group, and only if the absolute IgA, IgM, or IgG level was higher in convalescentphase serum samples than the mean of the serologic control group plus 2 SDs.
Data Analysis
Statistical significance for the differences in antibody levels was tested using the nonparametric Mann-Whitney U test when the independent variable had 2 levels and using the KruskalWallis H test when it had у3 levels. Comparison of categorical variables was performed by the x 2 test or Fisher's exact test for small samples. Analysis of acute IgG levels in association with clinical and laboratory findings was further performed after stratifying for smoking status. Effectiveness of protection by specific IgG levels among nonsmokers was calculated as 1 Ϫ ratio. Multivariate analysis was performed using a logistic risk regression model that included smoking status, level of specific anti-M. pneumoniae IgG, and military function (basic trainees or command staff). Data analysis was performed using SPSS, version 12.0 for Windows (SPSS). Diagnostic tests. Blood cell counts obtained from 28 of the patients with RTI (of whom 7 had pneumonia) were within the normal range. Patients who had pneumonia ( ) had n p 7 lower absolute lymphocyte counts (still within normal limits) than the remaining 21 patients with RTI ( vs. 1400 ‫ע‬ 258 cells/mL, respectively;
RESULTS
Febrile
). 2000 ‫ע‬ 465 P p .001 All patients were negative for respiratory syncytial virus, influenza viruses, parainfluenza viruses, adenoviruses, human metapneumovirus, C. pneumoniae, and L. pneumophila. Twenty-eight (table 4) . IgM seroconversion was, as might be expected, positively associated with low acute IgG levels in both smokers and nonsmokers.
DISCUSSION
M. pneumoniae outbreaks are well documented in the medical literature [3, 8-11, 23, 24] . However, many outbreaks are associated with relatively low numbers of concurrent cases and persist for months, whereas relatively few occur in short time periods, such as this one [12] . The explosive nature of this outbreak and the very early collection of samples enabled us to conduct a cohort study to assess the effect of prior immune status to M. pneumoniae and smoking habits of participants on the risk for morbidity, with minimal possible confounding.
That more trainees who did not have RTI tested positive for M. pneumoniae by the more sensitive real-time PCR compared with PCR1 might suggest that the M. pneumoniae bacterial load is lower in persons with milder infections or in asymptomatic individuals. This is in agreement with previous findings [25] . Asymptomatic children who are temporary carriers have been implicated as silent spreaders of the disease [26] . This suggests that a carrier state might exist in adults as well.
The low lymphocyte counts observed in the patients with pneumonia, although within normal limits, represent (to our knowledge) a new finding. Whether this is a result of the disease itself or whether it represents a preexisting state cannot be determined. Lower preexisting lymphocyte counts might be associated with greater susceptibility to infection and more severe morbidity, whereas M. pneumoniae infection contracted by individuals with higher lymphocyte counts may have a lower probability of progressing to pneumonia.
The unique scenario of this epidemic allowed us to investigate a few coexisting conditions that have been considered to influence M. pneumoniae infection. No significant association was observed between M. pneumoniae infection and the number and age of siblings or military function. We confirmed that smoking was significantly associated with a higher risk for respiratory infection with M. pneumoniae, as was suggested a few years ago [8] in a large, clinically defined outbreak of M. pneumoniae infection at a federal service training academy. The association of morbidity due to this pathogen with smoking is a relatively new observation. One possible explanation relates to M. pneumoniae pathogenesis; the attachment of M. pneumoniae to the respiratory epithelium is a prerequisite for later events that lead to disease onset [3] . Cigarette smoke is well known for its harmful effect on the mucociliary epithelium [27] , which plays an important role in protection against M. pneumoniae infection. Therefore, it is plausible that defective clearance of the organism from the upper respiratory tract as a result of the effects of smoking may contribute to the pathogenesis of this infection. Moreover, smoking is a well established risk factor for respiratory tract infection caused by other pathogens [28] .
Another important observation is that acute IgG levels were inversely associated with morbidity and with seroconversion of both IgM and IgA. Considering IgG as a marker of previous exposure to M. pneumoniae, this finding suggests that a significant protective immunity is elicited by previous exposure to M. pneumoniae. Indeed, a recent study revealed that at least 80% of healthy individuals in the 18-21-year-old age group were found to be seropositive by IgG assay, confirming previous exposure to M. pneumoniae [29] . McCormick et al. [30] observed that preexisting antibodies to M. pneumoniae measured by complement fixation conferred protection against both mild and severe disease that required hospitalization. However, antibodies found by complement fixation may represent recent exposure to M. pneumoniae, whereas our results demonstrate protective immunity that is not necessarily recent. According to our results, this protection only benefits nonsmokers. This novel finding is evidenced by the attack rate of RTI in 29.5% of immune nonsmokers, compared with 76.9%-85.7% in immune smokers and nonimmune individuals (table 4). The similar findings for IgM seroconversion-but not for PCR-further support the roles of smoking and low IgG levels as risk factors.
These findings may shed light on some of the reasons why M. pneumoniae vaccination studies conducted during the 1960s and 1970s showed variable results [31] [32] [33] . In these trials, the vaccine efficacy in M. pneumoniae-specific pneumonia ranged from 27% to 67%, depending on the method of M. pneumoniae detection; the variance for protection against M. pneumoniaespecific bronchitis was even higher, ranging from no efficacy to 87%. All the vaccines were tested in army-based facilities in which the prevalence of smoking exceeded 50% at the time [34] , which may have contributed to the lack of vaccine efficacy. This implies that vaccination might be effective in nonsmokers. From our data, the protective effect of positive prior IgG levels in nonsmokers can be calculated to be 65.5% (95% CI, 40%-80%), suggesting that vaccination may have a protective role in this group.
The outbreak on which we reported again emphasized the significant morbidity of an infection that is considered by most to be characterized by a mild course. Our study also defined another harmful consequence of smoking and illustrated the association of IgG levels and resistance to infection in nonsmokers. Furthermore, our analysis implied that the goal of finding an effective vaccine for protection against M. pneumoniae might be achievable. Further studies are thus warranted to reduce the burden of this ubiquitous pathogen.
